Spironolactone and Visicol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spironolactone (spironolactone) and Visicol (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate). Common drug interactions include hypoaesthesia among females and acute phosphate nephropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Spironolactone and Visicol. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Visicol?

Visicol has active ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. eHealthMe is studying from 471 Visicol users. Check the latest studies of Visicol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

12 people who take Spironolactone and Visicol together, and have interactions are studied.

Spironolactone and Visicol drug interactions.

What are the common drug interactions of Spironolactone and Visicol, by gender? *:

female:

Hypoaesthesia (reduced sense of touch or sensation)
Malaise (a feeling of general discomfort or uneasiness)
Blood pressure decreased
Renal failure acute (rapid kidney dysfunction)
Renal impairment (severely reduced kidney function)
Blood calcium decreased
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Memory impairment
Acute phosphate nephropathy (sudden damage to the kidneys caused by the formation of phosphate crystals)
Chronic kidney disease

male:

Acute phosphate nephropathy (sudden damage to the kidneys caused by the formation of phosphate crystals)
Dyslalia (inability to articulate comprehensible speech)
Chest pain
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypoaesthesia (reduced sense of touch or sensation)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Renal impairment (severely reduced kidney function)
Respiratory paralysis (respiratory failure)
Tetany (involuntary contraction of muscles)
Urine output decreased

What are the common drug interactions of Spironolactone and Visicol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acute phosphate nephropathy (sudden damage to the kidneys caused by the formation of phosphate crystals)
Dyslalia (inability to articulate comprehensible speech)
Hypoaesthesia (reduced sense of touch or sensation)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Renal impairment (severely reduced kidney function)
Respiratory paralysis (respiratory failure)
Tetany (involuntary contraction of muscles)
Urine output decreased
Blood creatinine increased
Blood urea increased

40-49:

n/a

50-59:

Renal impairment (severely reduced kidney function)
Acute phosphate nephropathy (sudden damage to the kidneys caused by the formation of phosphate crystals)
Chronic kidney disease
Dyslalia (inability to articulate comprehensible speech)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypoaesthesia (reduced sense of touch or sensation)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Renal failure (kidney dysfunction)
Respiratory paralysis (respiratory failure)
Tetany (involuntary contraction of muscles)

60+:

Malaise (a feeling of general discomfort or uneasiness)
Blood pressure decreased
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Nephropathy (damage to or disease of a kidney)
Post procedural complication
Rash
Hypoaesthesia (reduced sense of touch or sensation)
Renal failure acute (rapid kidney dysfunction)
Blood calcium decreased

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
High Blood Cholesterol: 3 people, 25.00%
Hypersensitivity: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Gastric Ph Decreased: 2 people, 16.67%
Bone Disorder: 2 people, 16.67%
Asthma: 2 people, 16.67%
Arthropathy: 2 people, 16.67%
Pain In Extremity: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and Visicol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously